Paul Hastings represented Seelos Therapeutics, Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group. Seelos Theraputics Inc. (NASDAQ: SEEL) announced a $5.55 million public...
Paul Hastings represented Seelos Therapeutics, Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group. Seelos Theraputics Inc. (NASDAQ: SEEL) announced a $5.55 million public...
You must be a Standard 1 Year member to access this content.